Enter your email address
Submit
Write your message
Volume 19, Issue 1 (2-2025)
IJT 2025, 19(1): 52-61 |
Back to browse issues page
Ethics code: AZHAR, 23/2023
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kandeel W A, Farag S A, Ali H M, Ashry M. Hormonal, Inflammatory Modulatory and Antioxidant Effects of Glycyrrhiza glabra L Extract in Polycystic Ovary Syndrome-Modeled Rats. IJT 2025; 19 (1) :52-61
URL: http://ijt.arakmu.ac.ir/article-1-1392-en.html
URL: http://ijt.arakmu.ac.ir/article-1-1392-en.html
1- PhD in Nutrition and Food Science, Faculty of Specific Education, Assiut University, Assuit, Egypt
2- PhD in Zoology, Zoology Department, Faculty of Science, Al-Azhar University, Assuit, Egypt ,mahmoud_ashry20@yahoo.com
2- PhD in Zoology, Zoology Department, Faculty of Science, Al-Azhar University, Assuit, Egypt ,
Abstract: (351 Views)
Abstract
One of the most prevalent metabolic conditions affecting women in their reproductive years that cause infertility or subfertility is Polycystic Ovary Syndrome, or PCOS. This was a pilot study to see whether Glycyrrhiza glabra L. aqueous extract (GAE) could prevent or treat PCOS in rats that had been given Estradiol®. Following acclimation, four groups of adult female Wistar albino rats weighing between 160 and 200 grams each were randomly assigned; Normal rats were used in the first group as a control, In the second group, normal rats were given 100 mg/kg of Glycyrrhiza glabra L orally for a period of six weeks, Third group: animals modelled by Polycystic Ovary Syndrome that were not treated served as a positive control, and lastly, Glycyrrhiza glabra L was administered to a group of animals modeled for PCOS for a period of six weeks. The obtained results showed that the PCOS caused by Estradiol® was significantly restored by Glycyrrhiza glabra L extracts; The results demonstrated a considerable reduction in serum levels of FSH, LH, PRL, testosterone, E2, TNF-α, IL-1β, IL-4, IL-6, and IL-10, along with a slight increase in insulin and progesterone levels, indicating that Glycyrrhiza glabra L extract significantly controlled PCOS deteriorations. Comparably, a noteworthy improvement in the oxidative status was noted; ovarian SOD, GPx, CAT, and GSH levels were significantly raised, accompanied by a notable decrease in MDA and NO levels. Additionally, urea, creatinine, cholesterol, triglycerides, and ALAT and ASAT activities were significantly reduced, and GAE showed nephro-hepatoprotective and anti-atherogenic capabilities; these results were in line with the comparable values of the healthy group. Histological analysis corroborated these results. In summary, GAE's phytochemicals, antioxidant, and anti-inflammatory qualities, along with its capacity to cause folliculogenesis, allowed it to effectively alleviate the effects of Estradiol®-induced polycystic ovary.
One of the most prevalent metabolic conditions affecting women in their reproductive years that cause infertility or subfertility is Polycystic Ovary Syndrome, or PCOS. This was a pilot study to see whether Glycyrrhiza glabra L. aqueous extract (GAE) could prevent or treat PCOS in rats that had been given Estradiol®. Following acclimation, four groups of adult female Wistar albino rats weighing between 160 and 200 grams each were randomly assigned; Normal rats were used in the first group as a control, In the second group, normal rats were given 100 mg/kg of Glycyrrhiza glabra L orally for a period of six weeks, Third group: animals modelled by Polycystic Ovary Syndrome that were not treated served as a positive control, and lastly, Glycyrrhiza glabra L was administered to a group of animals modeled for PCOS for a period of six weeks. The obtained results showed that the PCOS caused by Estradiol® was significantly restored by Glycyrrhiza glabra L extracts; The results demonstrated a considerable reduction in serum levels of FSH, LH, PRL, testosterone, E2, TNF-α, IL-1β, IL-4, IL-6, and IL-10, along with a slight increase in insulin and progesterone levels, indicating that Glycyrrhiza glabra L extract significantly controlled PCOS deteriorations. Comparably, a noteworthy improvement in the oxidative status was noted; ovarian SOD, GPx, CAT, and GSH levels were significantly raised, accompanied by a notable decrease in MDA and NO levels. Additionally, urea, creatinine, cholesterol, triglycerides, and ALAT and ASAT activities were significantly reduced, and GAE showed nephro-hepatoprotective and anti-atherogenic capabilities; these results were in line with the comparable values of the healthy group. Histological analysis corroborated these results. In summary, GAE's phytochemicals, antioxidant, and anti-inflammatory qualities, along with its capacity to cause folliculogenesis, allowed it to effectively alleviate the effects of Estradiol®-induced polycystic ovary.
Keywords: Polycystic Ovary Syndrome, Estradiol®, Glycyrrhiza glabra L, Anti-inflammatory, Antioxidant, Rat
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
The Iranian Journal of Toxicology
Arak University of Medical Sciences in collaboration with the Iranian Society of Toxicology
Website: http://ijt.arakmu.ac.ir
Email: tox.journal@gmail.com
